Celldex Therapeutics buy BiotechBee
Start price
07.09.22
/
80%
€29.80
Target price
31.12.25
€50.00
Performance (%)
35.57%
Price
26.07.24
€41.20
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Celldex Therapeutics has seen massive gains of 35.57%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Celldex Therapeutics | 21.893% | 21.893% | 31.210% |
iShares Core DAX® | 1.280% | 1.027% | 11.234% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% |
According to BiotechBee what are the pros and cons of Celldex Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 50,0